Triazolopyridine compounds as PIM kinase inhibitors

Compounds of Formula (I), in which A, B, R1, R1a, R2, R3, R4, R5, R6, and R7 have the meanings given in the specification, are receptor tyrosine inhibitors useful in the treatment of immune cell-associated diseases and disorders, such as inflammatory and autoimmune diseases.

Bibliographische Detailangaben

Hauptverfasser:	RAST BRYSON, CELESTE LAURA L, SCHLACHTER STEPHEN T, GROSS STEFAN D, GRESCHUK JULIE MARIE, TOPALOV GEORGE T, WRIGHT A. DALE, ZHAO QIAN, DELISLE ROBERT KIRK, HICKEN ERIK JAMES, ROBINSON JOHN E, ALLEN SHELLEY, PHENEGER JED, MUNSON MARK C, LYSSIKATOS JOSEPH P, JACKSON LEILA J, KALLAN NICHOLAS C, DAVIS T. GREGG, MARMSATER FREDRIK P
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!